Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HARMONY BIOSCIENCES HOLDINGS, INC.

(HRMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Pharmaceuticals
11:38aGerman Regulator Head Backs Pfizer-BioNTech's COVID-19 Vaccine Trial In US
MT
11:01aPfizer Receives European Commission's Approval for Lung Cancer Drug Lorviqua
MT
10:23aPfizer Secures European Commission's Approval for Lung Cancer Drug Lorviqua
MT
10:14aPfizer Gets EC OK for Lorviqua as First-Line Treatment for ALK-Positive Advanced Lung C..
DJ
07:27aMERCK : Molnupiravir Covid-19 Pill Effective Against Omicron in Lab Tests
DJ
06:02aEuropean Ombudsman Criticizes Commission's Handling Of Text Messages With Pfizer
MT
04:06aModerna, Pfizer Boosters Provide High Level of Protection Against Omicron, UK Health Se..
MT
01/27Pfizer/BioNTech, Moderna COVID-19 Booster Shots Provide Protection Against Death from O..
MT
01/27Health Care Outperform Amid Fading Thursday Markets
MT
01/27Health Care Stocks Still Outperforming Amid Fading Thursday Markets
MT
01/27Galapagos Names Former Johnson & Johnson Executive Paul Stoffels CEO; Shares Soar
MT
01/27European ADRs Move Higher in Thursday Trading
MT
01/27Pfizer Says Paxlovid COVID-19 Pill Received Positive Opinion From European Medicines Ag..
MT
01/27MeiraGTx Gets $30 Million Milestone Payment from Janssen Pharmaceuticals for Retinitis ..
MT
01/27European Medicines Agency Recommends Pfizer's COVID-19 Antiviral Pill
MT
01/27Pfizer Inc. Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment
CI
01/27PFIZER'S COVID-19 PILL GETS POSITIVE : Bloomberg
MT
01/27MeiraGTx Gets $30 Million Milestone Payment From Janssen Pharmaceuticals
DJ
01/27DA Davidson Lifts Johnson & Johnson's Price Target to $196 From $188, Citing 'Increased..
MT
01/26Pfizer-BioNTech, Moderna COVID-19 Jabs Shown Safe For Women Undergoing IVF in Study
MT
01/26Pfizer Seeks Role in US COVID-19 Vaccine Litigation to Protect Trade Secrets
MT
01/26Galapagos Appoints Former Johnson & Johnson Exec to Succeed Retiring CEO
MT
01/26Moderna starts trial for Omicron-specific booster shot
RE
01/26Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO
RE
01/26European shares show signs of recovery as Fed meeting awaited
RE
01/26Raymond James Adjusts Johnson & Johnson's Price Target to $185 From $178, Keeps Outperf..
MT
01/26NOVO NORDISK : JP Morgan remains Neutral
MD
01/26BioNTech Plans 50% Workforce Boost, $57 Million Investment At German Factory
MT
01/26ROCHE HOLDINGS AG : Deutsche Bank keeps its Buy rating
MD
01/26COVID-19 Severity Appears Lower With Omicron, But High Hospitalization Volume Could Str..
MT
01/26ROCHE HOLDINGS AG : Goldman Sachs reiterates its Buy rating
MD
01/26NOVO NORDISK : Goldman Sachs remains its Buy rating
MD
01/26ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating
MD
01/25Drugmaker Teva fueled opioid addiction in New York, jury finds
RE
01/25Health Care Stocks Still Trying to Overcome Midday Slide
MT
01/25US Labor Department's OSHA Revokes COVID-19 Vaccination Order for Large Employers
MT
01/25Health Care Stocks Resisting Steeper Tuesday Market Losses
MT
01/25Pfizer, BioNTech Launch Clinical Study of Omicron-Specific COVID-19 Vaccine
MT
01/25Liberum Capital Downgrades Novo Nordisk to Sell from Hold
MT
01/25Johnson & Johnson Posts Higher Fourth-Quarter Earnings; Sees COVID-19 Vaccine Sales of ..
MT
01/25Johnson & Johnson Forecasts COVID-19 Vaccine Sales Of Up To $3.5 Billion In 2022
MT
01/25Health Care Stocks Flat to Lower During Pre-Bell Tuesday
MT
01/25Johnson & Johnson Reports Earnings Results for the Full Year Ended January 02, 2022
CI
01/25Berenberg Bank Adjusts AbbVie's Price Target to $115 From $105, Maintains Hold Rating
MT
01/25Stocks Point to Weaker Session as US Futures Retreat Pre-Bell; Europe Rises, Asia Tumbl..
MT
01/25Pfizer, BioNTech to Study Omicron-Based COVID-19 Vaccine in Adults
MT
01/25Pfizer, BioNTech Start Clinical Study On Omicron-based Vaccine
MT
01/25Genmab's Darzalex Sales Hit $6 Billion In 2021
MT
01/25Johnson & Johnson Q4 Adjusted EPS, Revenue Rise; Company Issues 2022 Outlook
MT
01/25Pfizer Inc. and BioNTech SE Initiate Study to Evaluate Omicron-Based Covid-19 Vaccine i..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on HARMONY BIOSCIENCES HOLDINGS, INC.